FDA Claims 'Manipulated' Data Led to Drug's Approval, Proposes Withdrawal

(MedPage Today) -- The FDA said that "manipulated" data supported the approval of avacopan (Tavneos) for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, and the agency is proposing to withdraw the drug's marketing approval...
Source
MedPage Today
Opens original article in a new tab



